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Background & Aims: Microsatellite instability (replica tion error [RER]-positive phenotype) is a frequent ge netic alteration in gastric carcinomas. The clinical rela tionship between RER-positive and RER-negative gastric tumors Is poorly characterized. The aim of this study was to investigate the relationship between the number of altered microsatellite loci and the clinico pathologic features of gastric carcinoma. Methods: Five or 6 microsatellite loci were analyzed in 61 gastric carcinomas using polymerase chain reaction. Results: Twenty-one carcinomas (34.4%) had microsateilite in stability: 7 at 1 locus, 2 at 2 loci, and 12 at multiple loci. The comparison between the three groups (with none, 1 or 2, and more than 2 RER-positive loci) showed that RER-negative carcinomas and carcinomas with 1 or 2 RER-positive loci share features that differ from those of carcinomas with multiple RER-positive loci. The latter were all of the intestinal or atypical subtype and had lower DNA content, more prominent lymphoid infiltration, and less prevalent nodal metastases than carcinomas in the other two groups. The pa tients with carcinomas showing multiple RER-positive loci had a better prognosis. Conclusions: The finding of microsateilite instability in a single or few loci does not qualify a case as a mutator phenotype from a clini cal standpoint. Gastric tumors with multiple RER-positive loci have a particular clinicopathologic profile lead ing to a better outcome. R ecently, subtle genetic alterations resulting in expansions or contractions of simple repeated se quences, the so-called microsateilite instability (MI), have been described in several human cancers,1"5 An association between the presence of MI and certain clini copathologic characteristics was observed for sporadic co lorectal carcinomas.1"3,6,7 Lot he et al. 6 found that these differences relied on the number of altered microsateilite loci: carcinomas with multiple replication error (RER)positive loci were significantly associated with poor differentiation, diploidy, right-sided location, and pro longed survival, whereas carcinomas with a single RER-positive locus were similar to RER-negative carcinomas.6 MI at either one or m ultiple loci was also observed in other cancers, but no clinical or pathological differences were found between these two groups o f tumors.8,9
MI has been described as a frequent genetic alteration in gastric carcinomas,4,5,10"13 In a previous study,14 we investigated the frequency of RER-positive phenotype in a series of 34 sporadic gastric carcinomas by analyzing 4 -12 loci per case. W e confirmed the frequent occurrence of the RER-positive phenotype in gastric carcinomas (32.4%) and observed that RER-positive gastric tumors tended to occur as intestinal or atypical carcinomas in the antrum of elderly patients, to have abundant T -cell infiltration, and to have a relatively good prognosis.14 1 A In the aforementioned study, a presence of MI at a single locus was used as a criterion for classifying a case as RER-positive. Interestingly, only 1 o f the 34 carcino mas had MI in I locus.14 The remaining were either RER-negative (n = 23) or had MI at > 3 loci (n = 10), which suggested that there was a discontinuous distribu tion o f the number of affected loci in gastric carcinomas, leading to the constitution of two groups: cases w ith no or very few affected loci and those w ith m ultiple affected loci. Also, we observed that the carcinoma with MI at 1 locus shared the clinicopathologic features of the RERnegative carcinomas, thus differing from the other RERpositive cases.
In the present study, we extended the previous study of gastric carcinomas by analyzing a similar number of loci in all samples to better define the clinicopathologic profile(s) of RER-positive tumors and, in particular, to find whether there is a relationship between the number of altered microsateilite loci and the clinicopathologic features of gastric carcinoma.
Patients, Tissue Samples, and DNA Extraction
We analyzed 61 gastric carcinomas and paired samples from nonneoplastic mucosa of white patients who underwent surgery at the Hospital S. Joao, Oporto, Portugal. Thirty-four of the 61 cases have been reported previously.14 None of the patients included in the present series had a family history suggestive of hereditary nonpolyposis colorectal cancer. H&Estained sections were used to categorize tumors according to the classifications of the World Health Organization (WHO), 15 Lauren,16 and Ming.17 Penetration of the gastric wall and the presence and localization of lymph node metastases were re corded for all patients using standard criteria for pathological staging. Orcein-stained sections were used for the detection of vascular invasion. Lymphoid infiltration was subjectively scored as absent/minimal or moderate/abundant. Immunohistochemistry was used to classify the lymphocytic infiltration of the tumors according to the predominance of T or B lympho cytes using UCHL1 and L26 antibodies (Dako, Glostrup, Den mark), respectively. Ploidy was determined by flow cytometry in frozen samples as previously described. 18 From each patient, tissue fragments from primary tumors and nonneoplastic mucosa were immediately frozen in liquid nitrogen and stored at -70°C until use. The percentage of nonmalignant "contaminating" cells in the tumor samples was estimated by scoring adjacent histological cryostat sections, Microdissection of the specimens was performed whenever nec essary. Only samples with more than 50% of tumor cells were included in the study. High-molecular-weight DNA was iso lated using standard methods.ly
Microsateilite Marker Analysis
Six loci containing dinucleotide repeat sequences were studied: D1S158, D2S104, D5S82, D5S346, D6S252, and r ARG1. Primers specific for each locus were used to amplify the repeat and short flanking sequences in template DNA using polymerase chain reaction (PCR). PCR was performed ppin a 25-|lL volume of a mixture containing 10 mmol/L Tris-HC1 (pH 8.0), 50 mmol/L KC1,1.5 mmol/L MgCl2, 100 |Llmol/ L of each deoxynucleotide triphosphate except deoxycytidine triphosphate (dCTP), 10 Jimol/L dCTP, 1 JLiCi [a -32P]dCTP, 0.4 (Imol/L of each primer, 0.75 U Taq DNA polymerase, and 3 0 -5 0 ng genomic DNA. Thirty cycles of 94°C for 1 minute, 55°C for 1 minute, and 72°C for 1.75 minutes were performed with an initial denaturation step of 94°C for 5 minutes and a final extension step of 72°C for 10 minutes using a Perkin-Elmer 9600 GeneAmp PCR System (Perkin-Elmer, Norwalk, CT). PCR reaction products were diluted 1:1 with a loading buffer (98% formamide, 0,1% xylene cyanol, 0.1% bromophenol blue, and 10 mmol/L ethylenediaminetetraacetic acid [pH 8.0]) and then denatured for 5 minutes at 95°C. Subsequently, 2 |XL of this solution was electrophoresed in 6% polyacrylamide gels containing 6.9 mol/L u re a and 32.5% formamide for 2 -3 hours at 60 W. After electrophoresis, gels were fixed in 10% acetic acid, washed, dried, and exposed to x-ray film for 12 -24 hours. All scoring was performed independently by two observers. Five or 6 loci were analyzed per case. Of the 61 tumors, 16 tumors were analyzed at 5 loci and 45 tumors were analyzed at 6 loci. A case was considered positive when at least 1 locus had a different mobility band. All RER-positive loci were confirmed by a new PCR and electrophoretic run. After having verified that the 2 carcinomas w ith RERpositive at 2 loci had clinicopathologic features alm ost identical to those of carcinomas with 1 RER-positive locus, we divided the RER-positive carcinomas in two groups: a group of 9 carcinomas w ith 1 or 2 R ER-positive loci and a group of 12 carcinomas w ith m ultiple RERpositive loci ( Table 1) . Clinical and pathological data o f the gastric carcinomas are shown in Table 1 . Because w e perceived that most clinicopathologic features o f carcino mas with 1 or 2 RER-positive loci were similar to those of RER-negative carcinomas ( Table 1) Simplified version of WHO classification. rfin 10 cases, DNA index and S-phase fraction were not determined. Table 2) . Statistically significant differences were also observed re garding lymphoid infiltrate (P < 0.01) and D N A content (P < 0.005) ( Table 2 ). Sixty-seven percent of gastric carci nomas with more than 2 RER-positive loci had moderate or abundant lymphoid infiltrate in contrast to only 22% of carcinomas with none or few RER-positive loci. Lymphoid N A index, 1.48 ± 0.46) . 
Statistical Analysis

Statistical analysis was performed using the % 2 test with Yates' correction, Fisher's Exact Test, or Student's t test using
infiltration was mainly composed of T cells, as assessed by immunohistochemistry (data not shown). A ll carcinomas with MI at multiple loci were diploid or near diploid (aver age D N A index, 1.04 ± 0.07), and most carcinomas w ith out MI or with 1 or 2 affected loci had aneuploid D N A content (average D
The percentage of cases w ith lym ph node métastasés was lower (P = 0.08) in the group o f carcinomas w ith
Discussion
In a previous study» we detected MI in of 34 cases of gastric carcinomas1'1 and found that these RER-positive carcinomas were associated with some d inicopathologic features, as previously reported in studies on colorectal carcinomas,1 u '1 ?
In the present study, we extended die previous study All carcinomas with multiple RER-positive were clas sified as intestinal or atypical gastric carcinomas in keep ing with previous reports.10^12 The low frequency of MI in diffuse carcinomas does not seem to be an underrepre sentation caused by stromal contamination because, in the present study, we only included study samples with more than 50% of tumor cells. We also observed associashow that one cannot rely on the finding of a single or tions between the presence of the RER-positive phenoa few RER-positive loci to consider a gastrointestinal type and the occurrence of minimal or absent desmoplascarcinoma as being a mutator phenotype from a clinico-tic response (P < 0.05) and expanding growth pattern pathologic standpoint. It is likely that the drawing line (P = 0,09). These associations are not unexpected because distinguishing "positive" from "negative" cases will de pend on the number of loci analyzed and on the number and characteristics of the markers used in each study. Our finding of an association between the presence of deficiency may occur at different steps during tumor multiple RER-positive loci and the lower prevalence of progression. Carcinomas with 1 or 2 RER-positive loci lymph node metastization is in accordance with the negamay have acquired the RER-positive phenotype in an advanced phase of tumor progression, therefore not giv-
tive correlation found between MI and metastization, previously reported in gastric carcinomas11 and colorectal ing enough time to yield distinctive clinicopathologic carcinomas.1 The low prevalence of lymph node metastifeatures. In contrast, carcinomas with MI at multiple loci zation most likely accounts for the good outcome of the would have acquired a mismatch repair deficiency in earlier steps of tumor progression, thus leading to the accumulation of multiple mutations throughout the ge nome, including microsatellite and gene sequences.
patients with carcinomas with multiple RER-positive loci, as previously reported for colorectal cancer. 1 The statistically significant association between the presence of MI and moderate/abundant lymphoid in.fi 1-It is difficult or even impossible to evaluate the plausi-tration confirms our previous results14 and, together with bility of the aforementioned hypotheses without knowing the presence of Crohn's-like lymphoid reaction in colowhat is going on at the different mismatch repair genes rectal RER-positive carcinomas,7 supports the assumpthat may be involved in generating MI in gastric carcino tion that unrepaired errors in certain genes can lead to mas. However, if one takes in consideration that carcino-the appearance of new surface molecules and thereby mas with "few" RER-positive loci are mostly aneuploid trigger an immune response. This mechanism may ac-44 DOS SANTOS ET AL GASTROENTEROLOGY Vol. 110, No. 1 count for the better prognosis of patients with carcinomas with multiple RER-positive loci if one assumes that the immune response may lim it the invasive and/or meta static ability of the tumors. The mutator phenotype may also contribute for the better clinical outcome of patients with multiple RERpositive loci through the acquisition of a mutation bur den, which can yield deleterious mutations in vital genes.22,25 A mutational load may negatively condition the selective advantage conferred by favorable mutations in cancer-related genes, therefore leading to an indolent tumoral progression and low metastatic potential. This scenario is in agreement with the lower proliferative in dex of carcinomas and older age of patients with multiple RER-positive loci.
In summary, the finding of MI in a single or few loci does not qualify a gastric cancer case as a mutator phenotype from a clinical standpoint, whereas gastric carcinomas with multiple RER-positive loci have a par ticular clinicopathologic profile leading to a better out come.
